Private equity fund True North acquires minority stake in Bengaluru-based Anthem Bio

Set up by ex-Biocon executive Ajay Bharadwaj, Rs.1200-crore Anthem Biosciences competes with Biocon owned Syngene International and Hyderabad based GVK Bio. Outbidding global buyout funds, private equity fund True North is all set to acquire a minority stake in Anthem Biosciences, ET reported in January.